Equity · Healthcare
CGON
NASDAQCG Oncology (CGON)
The line runs 77 USD on 12 August through 74.79 USD on 9 November, on a scale from 50 to 80. Days the market did not trade hold the previous close, flat.
- Market cap
- 6.7B USD
- Revenue, year to Dec 2025
- 4.0M USD
- EPS, diluted, year to Dec 2025
- −2.08 USD
- 52-week range
- 37 USD – 79 USD
- Avg volume
- 57.3K
as of Nov 9, 2026
Have CG Oncology (CGON) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, CG Oncology insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 25 Jun 2026.
Form 4, 90 days to 10 Nov 2026, newest reported trade 15 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Oct 2026 | POST LEONARD EDirector | Sell | 1,000 | 62K USD |
| 15 Sep 2026 | POST LEONARD EDirector | Sell | 1,000 | 73K USD |
| 14 Aug 2026 | POST LEONARD EDirector | Sell | 1,000 | 75K USD |
| Sold | 3 open-market sales | 3,000 | $210K |
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Oct 2026 | POST LEONARD EDirector | Option exercise | 1,000 | 600 USD |
| 15 Sep 2026 | POST LEONARD EDirector | Option exercise | 1,000 | 600 USD |
| 14 Aug 2026 | POST LEONARD EDirector | Option exercise | 1,000 | 600 USD |
Which funds hold CG Oncology (CGON)?
1 of the 45 institutional funds we track reported a CG Oncology position for the quarter ended 30 Sep 2026 — a combined 33.8M USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 476,917 | 33.8M USD | +4.4% |
What has been filed or recorded for CG Oncology (CGON)?
The filings we hold for CG Oncology, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.64 USD | |
| 30 Sep 2026 | Financials | Total assets | 1.0B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 991.0M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.90 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.71 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −2.08 USD | |
| 31 Dec 2025 | Financials | Revenue | 4.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −161.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −2.08 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.57 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.54 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.45 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.41 USD |
What do people ask about CG Oncology (CGON)?
What did CG Oncology shares close at?74.79
CG Oncology closed at 74.79 USD on 9 Nov 2026, down 1.33% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is CG Oncology’s market cap?6.7B
CG Oncology is worth 6.7B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is CG Oncology’s revenue?4.0M
CG Oncology reported revenue of 4.0M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have CG Oncology insiders bought or sold shares recently?3 sales
In the 90 days to 10 Nov 2026, CG Oncology insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 25 Jun 2026. A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own CG Oncology?1 of 45
1 of the 45 funds we track reported a CG Oncology position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
When did CG Oncology last report earnings?−0.64
CG Oncology last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.64 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings